David H. Persing, EVP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 5,000 shares at $54.68 ($273K) on 2014-11-13, disclosed to the SEC on 2014-11-17.
Scheduled sale ($273k) by EVP, Chief Med/Tech Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CPHD | SELL | 2014-12-02 | $837K | — | Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-10-31 | $1.1M | — | Filing → |